Abstract
In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time. © 2003 Cancer Research UK.
Author supplied keywords
Cite
CITATION STYLE
Porteous, M., Dunckley, M., Appleton, S., Catt, S., Dunlop, M., Campbell, H., & Cull, A. (2003). Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study. British Journal of Cancer, 89(8), 1400–1402. https://doi.org/10.1038/sj.bjc.6601332
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.